iPierian Nabs $28M Backing From Glaxo and Biogen Idec

Biogen and GlaxoSmithKline join Google Ventures in backing iPierian, a San Francisco-based company that is working on technology that will transform ordinary adult cells into a stem-cell like state. If successful, the technique could be applied to the treatment of diseases like Alzheimer’s and ALS, without falling prey to the government intervention that has plagued embryonic stem cell research as of late.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail